70
Views
22
CrossRef citations to date
0
Altmetric
Original Research

Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts

&
Pages 2341-2348 | Published online: 21 Sep 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Job J. M. H. van Bragt, Susanne J. H. Vijverberg, Els J. M. Weersink, Levi B. Richards, Anne H. Neerincx, Peter J. Sterk, Elisabeth H. D. Bel & Anke H. Maitland-van der Zee. (2018) Blood biomarkers in chronic airways diseases and their role in diagnosis and management. Expert Review of Respiratory Medicine 12:5, pages 361-374.
Read now
Donald P Tashkin & Charlie Strange. (2018) Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy?. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2587-2601.
Read now
Donald P Tashkin & Michael E Wechsler. (2018) Role of eosinophils in airway inflammation of chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 335-349.
Read now
Eylem Acartürk Tunçay, Zuhal Karakurt, Emine Aksoy, Cuneyt Saltürk, Sinem Gungor, Nezihe Ciftaslan, İlim Irmak, Dilek Yavuz, Birsen Ocakli & Nalan Adıgüzel. (2017) Eosinophilic and non-eosinophilic COPD patients with chronic respiratory failure: neutrophil-to-lymphocyte ratio as an exacerbation marker. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 3361-3370.
Read now
Shih-Lung Cheng, Hsu Hui Wang & Ching-Hsiung Lin. (2017) Effect of allergic phenotype on treatment response to inhaled bronchodilators with or without inhaled corticosteroids in patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 2231-2238.
Read now

Articles from other publishers (17)

Mauro Mormile, Ilaria Mormile, Salvatore Fuschillo, Francesca Wanda Rossi, Laura Lamagna, Pasquale Ambrosino, Amato de Paulis & Mauro Maniscalco. (2023) Eosinophilic Airway Diseases: From Pathophysiological Mechanisms to Clinical Practice. International Journal of Molecular Sciences 24:8, pages 7254.
Crossref
Marcello Ferrari1, Michela Pizzini1, Lucia Cazzoletti2, Valentina Ermon1, Sergio De Marchi1, Luca Giuseppe Dalle Carbonare1, Ernesto Crisafulli1 & Francesco Spelta1. (2022) Circulating eosinophil levels and lung function decline in stable chronic obstructive pulmonary disease: a retrospective longitudinal study. Jornal Brasileiro de Pneumologia, pages e20220183.
Crossref
Elena V. Bolotova, Anna V. Dudnikova & Larisa V. Shulzhenko. (2022) Experience of using a triple fixed combination in the treatment of patients with chronic obstructive pulmonary disease. Terapevticheskii arkhiv 94:3, pages 396-400.
Crossref
Meropi Karakioulaki & Daiana Stolz. 2022. Eosinophilic Lung Diseases. Eosinophilic Lung Diseases 100 118 .
Li-Yen Lee, Geena Suet Yin Hew, Meenu Mehta, Shakti D. Shukla, Saurabh Satija, Navneet Khurana, Krishnan Anand, Harish Dureja, Sachin Kumar Singh, Vijay Mishra, Pankaj Kumar Singh, Monica Gulati, Parteek Prasher, Alaa A.A. Aljabali, Murtaza M. Tambuwala, Lakshmi Thangavelu, Jithendra Panneerselvam, Gaurav Gupta, Flavia C. Zacconi, Madhur Shastri, Niraj Kumar Jha, Dikaia Xenaki, Ronan MacLoughlin, Brian G. Oliver, Dinesh Kumar Chellappan & Kamal Dua. (2021) Targeting eosinophils in respiratory diseases: Biological axis, emerging therapeutics and treatment modalities. Life Sciences 267, pages 118973.
Crossref
Tao Liu, Zi-Jian Xiang, Xiao-Meng Hou, Jing-Jing Chai, Yan-Li Yang & Xiao-Tong Zhang. (2021) Blood eosinophil count-guided corticosteroid therapy and as a prognostic biomarker of exacerbations of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Therapeutic Advances in Chronic Disease 12, pages 204062232110287.
Crossref
Guangming Dai, Yajuan Ran, Jiajia Wang, Xingru Chen, Junnan Peng, Xinglong Li, Huojin Deng, Min Xiao & Tao Zhu. (2020) Clinical Differences between Eosinophilic and Noneosinophilic Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Multicenter Cross-Sectional Study. Mediators of Inflammation 2020, pages 1-9.
Crossref
Ghassan Hamad, Alan Rigby & Alyn H. Morice. (2020) An audit of COPD: diagnosis and management in general practice. ERJ Open Research 6:4, pages 00330-2020.
Crossref
Marjan Kerkhof, Isha Chaudhry, Ian D. Pavord, Marc Miravitlles, Chin Kook Rhee, David M.G. Halpin, Omar S. Usmani, Rupert Jones, Janwillem Kocks, Marianna Alacqua, Tamsin Morris, Alan Kaplan & David B. Price. (2020) Blood eosinophil count predicts treatment failure and hospital readmission for COPD. ERJ Open Research 6:4, pages 00188-2020.
Crossref
Christine F. McDonald. (2020) Eosinophils in chronic obstructive pulmonary disease. Current Opinion in Pulmonary Medicine 26:2, pages 169-174.
Crossref
S N Avdeev, N V Trushenko, Z M Merzhoeva, M S Ivanova & E V Kusraeva. (2019) Eosinophilic inflammation in chronic obstructive pulmonary disease. Terapevticheskii arkhiv 91:10, pages 144-152.
Crossref
Salvatore Fuschillo, Antonio Molino, Cristiana Stellato, Andrea Motta & Mauro Maniscalco. (2019) Blood eosinophils as biomarkers of therapeutic response to chronic obstructive pulmonary disease: Still work in progress. European Journal of Internal Medicine 68, pages 1-5.
Crossref
Tinè, Biondini, Semenzato, Bazzan, Cosio, Saetta & Turato. (2019) Reassessing the Role of Eosinophils as a Biomarker in Chronic Obstructive Pulmonary Disease. Journal of Clinical Medicine 8:7, pages 962.
Crossref
Olorunfemi A. Oshagbemi, Frits M.E. Franssen, Dionne C.W. Braeken, Yvonne Henskens, Emiel F.M. Wouters, Anke-Hilse Maitland-van der Zee, Andrea M. Burden & Frank de Vries. (2018) Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality. Pharmacoepidemiology and Drug Safety 27:11, pages 1191-1199.
Crossref
Guy Brusselle, Ian D. Pavord, Sarah Landis, Steven Pascoe, Sally Lettis, Nikhil Morjaria, Neil Barnes & Emma Hilton. (2018) Blood eosinophil levels as a biomarker in COPD. Respiratory Medicine 138, pages 21-31.
Crossref
Hendrik J. Prins, Ruud Duijkers, Rene Lutter, Johannes M. Daniels, Paul van der Valk, Margreet Schoorl, Huib A. Kerstjens, Tjip S. van der Werf & Wim G. Boersma. (2017) Blood eosinophilia as a marker of early and late treatment failure in severe acute exacerbations of COPD. Respiratory Medicine 131, pages 118-124.
Crossref
Marc Miravitlles. (2017) Diagnosis of asthma–COPD overlap: the five commandments. European Respiratory Journal 49:5, pages 1700506.
Crossref